"McKinsey Settles for $78M in Opioid Crisis Case Linked to Purdue Pharma"

McKinsey & Co has agreed to a $78 million settlement with U.S. health insurers and benefit plans over allegations that its consulting services for drug companies, including Purdue Pharma, contributed to the opioid epidemic. This settlement adds to McKinsey's previous payouts, totaling over $871 million, to various plaintiffs including state attorneys general, local governments, and Native American tribes. McKinsey maintains that its past work was lawful and has ceased advising on opioid-related business since 2019. The opioid crisis has led to numerous lawsuits and over $50 billion in settlements from various entities in the pharmaceutical industry.